TLR4 and breast carcinoma: It has been found to protect against breast cancer tumorigenesis via the Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathways [14] and to suppress colorectal cancer by inducing apoptosis and inhibiting glycolysis [15].